New vaccine may prevent multiple strains of the flu
Stephen FellerATHENS, Ga., March 29 (UPI) -- Scientists developed a vaccine for H1N1 influenza that protects against pandemic and seasonal strains of the virus, they report in a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 29, 2016 Category: Consumer Health News Source Type: news
New flu vaccine protects against multiple strains including H1N1
Researchers have announced the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 29, 2016 Category: Science Source Type: news
UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza
(University of Georgia) Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models. They published their findings in the Journal of Virology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 29, 2016 Category: Biology Source Type: news
Sanofi Pasteur uses novel technology for development of a 2nd-gen influenza vaccine
(Sanofi Pasteur) Sanofi Pasteur announces published data on a vaccine strategy that elicited a broadly-reactive response against seasonal and pandemic H1N1 influenza viruses in mice. The article, entitled 'Design and characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses,' appears in the current issue of the Journal of Virology. Sanofi Pasteur is presenting the data tomorrow, March 30, at the 2016 World Vaccine Congress being held in Washington, DC. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 29, 2016 Category: Biology Source Type: news
6 Things Every Traveler Should Know About The Zika Virus
If there's one thing we know about travelers, it's that they have a lot on their minds. And who can blame them? From terrorist attacks to travel warnings in popular vacation destinations across the globe, there's plenty to cause concern for the wanderlust crowd among us. Sadly, the Zika virus is merely the latest alarm bell for travelers. If you're wondering whether it's a smart idea to modify your plans in light of recent outbreaks, here's what you need to know. 1. What are the latest developments? The White House has requested $1.8 billion in emergency funding from Congress to combat the virus. A Reuters/lpsos poll relea...
Source: Healthy Living - The Huffington Post - February 18, 2016 Category: Consumer Health News Source Type: news
Josh Hadfield who developed narcolepsy after H1N1 swine flu jab awarded £120k
Josh Hadfield, from Somerset, developed narcolepsy after the Pandremix vaccine 6 years ago. The vaccine is associated with a 14-fold increase in a child's risk of developing the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - February 3, 2016 Category: Consumer Health News Source Type: news
Narcolepsy boy wins vaccine damages
A boy with a rare sleeping illness caused by a swine flu vaccine wins £120,000 in damages. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 3, 2016 Category: Consumer Health News Source Type: news
Why Are We Seeing an Explosion of New Viruses Like Zika?
Zika virus, Ebola, Middle East Respiratory Syndrome (MERS) coronavirus, Severe Acute Respiratory Syndrome (SARS) coronavirus, Nipah virus, Hendra virus, bird flu, swine flu -- these viruses have all grabbed international attention in recent years. In the past few decades the world has witnessed an alarming surge in emerging infectious diseases (EIDs). Since 1980, new pathogens have emerged in the human population at a rate of about three each year. Why are we seeing such a surge in new pathogens? One could argue that some of the pathogens may not be new at all; they could have circulated among humans for centuries and ar...
Source: Science - The Huffington Post - February 1, 2016 Category: Science Source Type: news
Swine flu reaches 'epidemic' proportions in St Petersburg
Dozens have died in a seasonal outbreak of the killer flu virus sweeping across former Soviet countries (Source: The Telegraph : Swine Flu A H1N1)
Source: The Telegraph : Swine Flu A H1N1 - January 25, 2016 Category: Infectious Diseases Tags: Russia St Petersburg Ukraine Moscow Soviet swine flu vaccine eastern Ukraine swine flu Source Type: news
H1N1 Flu Vaccine - Immunity Only Lasts 2 Years
It is generally believed that individuals who get the H1N1 flu vaccine lose their immunity to the H1N1 flu virus in about 10 years, but according to a recent analysis led by The Hong Kong Polytechnic University (PolyU) immunity lasts for two years. (Source: Disabled World)
Source: Disabled World - November 1, 2015 Category: Disability Tags: H1N1 Swine Flu Virus Source Type: news
H1N1 Flu Vaccine - Immunity Only Lasts 2 Years
Research led by The Hong Kong Polytechnic University discovers immunity from H1N1 with vaccine shot only lasts for two years (Source: Disabled World)
Source: Disabled World - November 1, 2015 Category: Disability Tags: H1N1 Virus Source Type: news
Scientists Hope Tracking Winter Flu Will Help Close Pandemic Knowledge Gap
ImageContent(562e45c2e4b0aac0b8fd7c69,562e42a91900002e00b94dab,Image,HectorAssetUrl(562e42a91900002e00b94dab,Some(),Some(jpeg)),ViktorCap via Getty Images,) Anyone who goes down with flu in Europe this winter could be asked to enroll in a randomized clinical trial in which they will either be given a drug, which may or may not work, or standard advice to take bed rest and paracetamol. Those who agree could be helping the world prepare for the next potentially deadly disease pandemic as well as helping scientists who are now desperate to plug gaps in knowledge left by previous missed opportunities. Scientists are largely in...
Source: Science - The Huffington Post - October 26, 2015 Category: Science Source Type: news
FDA and access to medical countermeasures during public health emergencies
By: Brooke Courtney, J.D., M.P.H.
Just weeks after witnessing the fall of the World Trade Center on Sept. 11, 2001, I was a student volunteer in a New York City hospital emergency department when several people arrived saying they had been exposed to anthrax.
One had even brought a small plastic bag holding white powder. Around this time, the media was reporting on letters mailed that were laced with white powder confirmed to be Bacillus anthracis, which causes anthrax.
At the hospital, we wondered whether we might become exposed to anthrax and how it could be prevented or treated. We quickly escorted the patients who had ...
Source: Mass Device - October 13, 2015 Category: Medical Equipment Authors: MassDevice Tags: Blog FDA Source Type: news
Narcolepsy cases linked to flu vaccine subject to new compensation dispute
Lawyers dispute claims over Pandemrix swine flu vaccine which was withdrawn after doctors noticed rise in narcolepsy casesGovernment lawyers are seeking to block compensation payments to people who developed the devastating sleep disorder, narcolepsy, as a result of a faulty swine flu vaccine. The Pandemrix vaccine made by GlaxoSmithKline (GSK) was given to 6 million people in Britain and millions more across Europe during the 2009-10 swine flu pandemic, but was withdrawn when doctors noticed a rise in narcolepsy cases among those who received the jab. Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 25, 2015 Category: Science Authors: Ian Sample Science editor Tags: Vaccines and immunisation Drugs Science Biology Health Society UK news Court of appeal Sleep Swine flu GlaxoSmithKline Pharmaceuticals industry & wellbeing Source Type: news
Get the flu vaccine, reduce your risk of death
Last year was a lousy year for the flu vaccine. Hospitalizations for flu hit a nine-year high, and the vaccine prevented flu in only 23% of all recipients, compared with 50% to 60% of recipients in prior years.
Why does the flu vaccine work well in some winters and not others? The flu vaccine primes the immune system to attack two proteins on the surface of the influenza A virus, hemagglutinin (H) and neuraminidase (N). Different flu strains have different combinations of these proteins — for example, the strains targeted by recent flu vaccines are H3N2 and H1N1.
Unfortunately, the influenza virus is microbiology’s ans...
Source: New Harvard Health Information - September 15, 2015 Category: Consumer Health News Authors: John Ross, MD, FIDSA Tags: Cold and Flu Vaccines Flu Shot flu vaccine Source Type: news
